Skip To Main Content
  • Article
  • Source: Campus Sanofi

Aumento de peso y uso de insulina

Análisis de las preocupaciones sobre el aumento de peso asociado al tratamiento con insulina en diabetes.

Debes ser un profesional de la salud para continuar leyendo este contenido.

¿Eres un profesional de la salud?

Regístrate para obtener acceso exclusivo a las últimas noticias sobre avances científicos y a recursos que mejoren la vida de tus pacientes.

Obtenga acceso a información para profesionales de la salud y edite los temas relevantes para usted en su perfil.

¿Olvidó su contraseña?
¿Aún no está registrado? Register
The account is under our identity verification process. When complete you will receive a confirmation email and you will be able to access the area dedicated to you.

Por favor revise su correo electrónico para ver el correo electrónico de verificación.

Gracias por registrarse, revise su correo electrónico para completar el registro.

No tienes el rol verificado correcto para ver este contenido.

Registro

¡Email enviado!
Este correo electrónico está disponible.

1 letra mayúscula
1 letra minúscula
1 numero
8 caracteres

Tus contraseñas coinciden.

Áreas de interés

 

Seleccione sus áreas de interés

Tratamiento de datos personales

*
¿Ya tienes una cuenta? |

Revisa tu bandeja de entrada de correo electrónico para activar tu cuenta

¡Email enviado!

Se ha enviado un correo electrónico de verificación al correo electrónico con el que se registró. Para activar su cuenta, haga clic en el enlace de este correo electrónico. Si no ha recibido el correo electrónico de verificación, haga clic en el botón a continuación.

De vuelta a casa

Welcome to Sanofi Campus

g

Referencias

  1. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes—causes, effects and coping strategies. Diabetes Obes Metab. 2007;9(6):799-812.
  2. Polonsky WH, Capehorn M, Belton A, et al. Physician-patient communication at diagnosis of type 2 diabetes and its links to patient outcomes: New results from the global IntroDia study. Diabetes Res Clin Pract. 2017;127:265-274.
  3. Dickinson JK, et al. The use of language in diabetes care and education. Diabetes Care. 2017;40(12):1790-1799.
  4. Bolli GB, Home PD, Porcellati F, et al. The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes. Diabetes Care. 2025;48(5):671-681.  
  5. Heller S, Buse J, Fisher M, et al. Insulin degludec, an ultra-long acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin as part in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet. 2012;379(9825):1489-1497.  
  6. Young-Hyman D, de Groot M, Hill-Briggs F, et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016;39(12):2126-2140.
  7. Essien O, Otu A, Umoh V, et al. Intensive Patient Education Improves Glycaemic Control in Diabetes Compared to Conventional Education: A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital. PLoS ONE. 2017;12(1):e0168835.
  8. Mubeen F, Low Wang CC, Al Maradni A, Shivaswamy V, Sadhu AR. Digital Health and Shared Decision-Making in Diabetes Care – A Survey Initiative in Patients and Clinicians. Endocr Pract. 2023;29(7):538-545. doi:10.1016/j.eprac.2023.04.012  
  9. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-1603.
  10. Colberg SR, Sigal RJ, Yardley JE, et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079.
  11. Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790-1799.
  12. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286(10):1218-1227.
  13. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(6):1433-1438.
  14. Francois ME, Baldi JC, Manning PJ, et al. 'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance. Diabetologia. 2014;57(7):1437-1445.
  15. Surwit RS, van Tilburg MAL, Zucker N, et al. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care. 2002;25(1):30-34.  
  16. Kuritzky L, Reid TS, Wysham CH. Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers. Clin Diabetes. 2019;37(4):368-376.  
  17. Evert AB, Dennison M, Gardner CD, et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care. 2019;42(5):731-754.
  18. Camelon KM, Hådell K, Jämsén PT, et al. The Plate Model: A visual method of teaching meal planning. J Am Diet Assoc. 1998;98(10):1155-1158.
  19. Dellasega C, Añel-Tiangco RM, Gabbay RA. How patients with type 2 diabetes mellitus respond to motivational interviewing. Diabetes Res Clin Pract. 2012;95(1):37-41.  
  20. Holman RR, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589.
  21. Laiteerapong N, et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care. 2019;42:416–426.
  22. Hanefeld M, et al. Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update. Diabetes Ther. 2020;11:1645–1666.
  23. PwC, EFPIA. Revealing policy barriers in diabetes care: how we can improve outcomes. 2023 May [consultado el 18 de junio de 2025]. Available from: Disponible en:  https://www.efpia.eu/media/676746/revealing-policy-barriers-in-diabetes-care-how-we-can-improve-outcomes.pdf 
MAT-AR-2502740 2027-10-22